Insulinoma – how to localize the tumor?

  • Saša Kiković Military Medical Academy, Clinic of Endocrinology, Belgrade, Serbia
  • Ivan Tavčar Military Medical Academy, Clinic of Endocrinology, Belgrade, Serbia
  • Tamara Dragović Military Medical Academy, Clinic of Endocrinology, Belgrade, Serbia
  • Petar Ristić Military Medical Academy, Clinic of Endocrinology, Belgrade, Serbia
  • Jelena Karajović Military Medical Academy, Clinic of Endocrinology, Belgrade, Serbia
  • Dejan Marinković Military Medical Academy, Clinic of Endocrinology, Belgrade, Serbia
  • Nenad Perišić Military Medical Academy, Clinic of Gastroenterology, Belgrade, Serbia
  • Siniša Rusović Military Medical Academy, Institute of Radiology, Belgrade, Serbia
  • Zoran Hajduković Military Medical Academy, Clinic of Endocrinology, Belgrade, Serbia
Keywords: insulinoma;, diagnosis;, calcium gluconate;, injections, intra-arterial;, sensitivity and specificity.

Abstract


Background/Aim. Arterial stimulation with calcium and venous sampling (ASVS) enables us to reach the goal of avoiding that any patient with insulinoma undergoes a blind surgical exploration. Since ASVS is both a functional and morphological localization procedure, its sensitivity is not influenced by factors that are causing the insensitivity of usual anatomical and morphological procedures. Based on our own experience in preoperative localization of insuli­noma, we indented to show why we believe that ASVS should be performed to all patients regardless of data col­lected from other preoperative localization methods. Meth­ods. We have analyzed the accuracy of preoperative local­ization methods retrospectively. First anatomical and mor­phological procedures like transabdominal ultrasound (US), endoscopic ultrasound (EUS), computed tomography (CT) and magnetic resonance imaging (MRI) were done. Then we analyzed the data collected during a functional procedure which, at the same time, allows regionalization (ASVS). To estimate the accuracy, the results of every single method were correlated with the operative findings in all sixteen cases. Results. Prior to ASVS, fourteen patients underwent US, fifteen had CT, MRI was performed in eight patients and EUS in thirteen. Using only one of these methods en­abled identification of tumors in five patients, using two methods in six patients while three and four in one patient each. For three patients, none of these methods was suc­cessful. ASVS revealed that all seen tumors were functional except three of the six visualized with two methods (US and EUS). In two of these three cases, US and EUS localized the tumors in pancreatic tail/body while ASVS accurately identified the tumors in pancreatic head. For these patients US and EUS showed false positive results. In the third of these patients EUS showed the tumor localized in pancre­atic head, while US and ASVS accurately pointed to tail. This, too, was a false positive result of EUS. ASVS success­fully provided regionalization data in three patients where other visualization methods failed. Operative and later his­tological findings confirmed the accuracy of ASVS in all sixteen patients including two patients that previously un­derwent distal pancreatectomy based on false positive EUS findings. Conclusion. Two patients, with accurate insuli­noma regionalization in pancreatic head, obtained with ASVS, previously underwent unsuccessful distal pancre­atectomy based on the false positive EUS findings. The same goes to three other patients with the false positive re­sults obtained with other anatomical and morphological findings, as well as those three patients that had no preop­erative visualization with other methods prior to ASVS. Therefore we suggest ASVS performing in each suspected insulinoma patient before the surgery, regardless of the data collected using other methods. This would enable us to test functional characteristics of visualized findings and to re­gionalize part of pancreas with uncontrolled insulin secre­tion when no suspicious changes were found.

References

REFERENCE

Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning in¬sulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66(7): 711‒9.

Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Sea¬quist ER. Service FJ; Endocrine Society. Evaluation and man¬agement of adult hypoglycemic disorders: an Endocrine Soci¬ety Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94(3): 709‒28.

Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau WJ, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab 2009; 94(4): 1069‒73.

Guettier J, Kam A, Chang R, Skarulis MC, Cochran C, Alexander RH, et al. Localization of insulinomas to regions of the pan-creas by intraarterial calcium stimulation: The NIH experi-ence. J Clin Endocrinol Metab 2009; 94(4): 1074‒80.

Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gas-tro¬enterol 2013; 19(6): 829‒37.

Druce MR, Muthuppalaniappan VM, O'leary B, Chew SL, Drake WM, Monson JP, et al. Diagnosis and localisation of insulino-ma: The value of modern magnetic resonance imaging in con-junc¬tion with calcium stimulation catheterisation. Eur J En-docrinol 2010; 162(5): 971‒8.

Grant CS, Grant MD. Insulinoma. Best Pract Res Clin Gastro-en¬terol 2005; 19(5): 783‒98.

Doppman JL, Miller DL, Chang R, Shawker TH, Gorden P, Nor-ton JA. Insulinomas: localization with selective intraarterial in-jec¬tion of calcium. Radiology 1991; 178(1): 237‒41.

O'Shea D, Rohrer-Theurs AW, Lynn JA, Jackson JE, Bloom SR. Lo¬calization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab 1996; 81(4): 1623‒7.

Baba Y, Miyazono N, Nakajo M, Kanetsuki I, Nishi H, Inoue H. Lo¬calization of insulinomas. Comparison of conventional ar-te¬rial stimulation with venous sampling (ASVS) and superse-lec¬tive ASVS. Acta Radiol 2000; 41(2): 172‒7.

Elston MS, Swarbrick MJ, Conaglen JV. Insulinoma localization using hepatic venous sampling with selective arterial calcium stimulation: should a fixed calcium dose be used?. Clin Endo-crinol (Oxf) 2005; 63(4): 480‒1.

Rostambeigi N, Thompson GB. What should be done in an oper-at¬ing room when an insulinoma cannot be found? Clin Endo-crinol (Oxf) 2009; 70(4): 512‒5.

Morganstein DL, Lewis DH, Jackson J, Isla A, Lynn J, Devendra D, et al. The role of arterial stimulation and simultaneous ve-nous sampling in addition to cross-sectional imaging for locali-sation of biochemically proven insulinoma. Eur Radiol 2009; 19(10): 2467‒73.

Published
2021/01/13
Section
Original Paper